Source: Flexible X-ray detector made with lead-free materials performs well in early testsRead More

Source: Annual MRI surveillance of low-risk prostate cancer drops biopsies while preserving life expectancyRead More

Source: AI carries ‘enormous potential’ to transform cardiac MRI, reduce scan times without using contrastRead More

Source: Unsupervised artificial intelligence predicts COVID-19 progression, survival rates based on CT scansRead More

Source: Supplemental, short-protocol MRI a cost-effective addition for stroke patients in the EDRead More

Astellas’ $3 billion bet on Audentes Therapeutics has hit yet another setback. Months after getting a clinical hold lifted, Astellas has voluntarily paused a gene therapy clinical trial after a patient suffered liver problems at the lower, supposedly safer dose. Source: After cutting dose because of deaths, Astellas pauses gene therapy trial as new liver...Read More

COVID-19 wasn’t even in the picture when mRNA was developed, but with the regulatory runway cleared, biotechs that have been working on the tech for years are ready for liftoff. Yes, Moderna and BioNTech are the rock stars in the business—launched to household name status with the COVID-19 vaccines at the end of 2020. But...Read More

Download this whitepaper to learn more. Source: How Digital Transformation Can Lead the Evolution of Pharmaceutical Operations Free White PaperRead More

Through world-leading genetic work, NSW researchers are discovering why about 50% of melanomas don’t respond to immunotherapy. Over the past decade, immunotherapy drugs have become the standard treatment for metastatic (or Stage IV) melanomas. These drugs help someone’s immune system recognise and fight a tumour by preventing tumour cells from obstructing the body’s immune checkpoints....Read More

Source: Artificial intelligence predicts delayed radiology turnaround times during nights and weekendsRead More